About Prescient Medicine
About Prescient Medicine
The power to predict can strengthen the ability to heal and prevent disease. That’s why Prescient Medicine is dedicated to uncovering critical insights that enable more informed, more effective care. We see this as the next frontier in healthcare, and we’re passionate about bringing it to life today. The need is critical, the technology is ready, and the time is now.
Through our expertise in pharmacology, chemistry, pathology, pharmacogenomics, and toxicology, we’ve created powerful tests and analytics that deliver the right information necessary to make the correct choice at the appropriate time. Our genetic-based tests target patient outcomes and management in two key areas: medication interaction and medication efficacy. With actionable results in hand, physicians can better prescribe compatible therapies and also predict how a patient might react to potential treatment options.
And Prescient is just getting started. We’ve discovered that equipping doctors with deeper predictive intelligence opens the door to entirely new possibilities in personalized medicine. So we’re continuing to expand our industry-leading portfolio by building new procedures, kits, and online apps. We’re also partnering with device manufacturers and institutions to uncover new ways to harness the power of our advanced analytics.
It’s all in service of our belief that the next frontier in healthcare delivery has already arrived—and we’re honored to be among its pioneers.
Dr. Keri J. Donaldson
Chief Executive Officer & Medical Director
Dr. Keri Donaldson’s work as Medical Director and CEO of Prescient Medicine is fueled by an extensive background in the fields of pathology, genomics, and diagnostics. An active ad hoc reviewer and consultant, Dr. Donaldson has earned a reputation as an innovative member of the medical community and garnered key positions within respected institutions and national committees. Throughout his time with Penn State College of Medicine, he’s served as Assistant Professor of Pathology (also at Hershey Medical Center), Assistant Professor of Public Health Sciences (a joint appointment also at Hershey Medical Center), Assistant Professor of Medicine, and Assistant Professor of Biochemistry. He was certified as a diplomate of both the American Board of Pathology and the National Board of Medical Examiners, and is a frequent guest speaker at regional and national symposia. Dr. Donaldson holds a BS from Pennsylvania State University, an MD from Temple University School of Medicine, and a master of science in clinical epidemiology (MSCE) from the University of Pennsylvania School of Medicine.
Chief Information Officer
With more than 20 years of experience in systems development, implementation and integration, Brian Eichenberger delivers a wide range of expertise in his work with Prescient Medicine. He serves as head of the Technology Team in the development of laboratory information systems, analytics, and smart app platforms. His responsibilities include the vision, strategy, and implementation of all aspects of information technology, telecommunications, and client operations. Before joining Prescient Medicine, Brian held multiple leadership positions at CVS Health, including a Senior Director role in which he managed day-to-day client operations and technology development for an $18 billion client portfolio with a $300 million technology budget. His time spent supporting automating and initiatives within new health plan features, regulatory and compliance controls, disease management applications, prescription fulfillment, and adjudication solutions earned him multiple “CVS Breakthrough” awards in recognition of technology achievements and innovation. Brian has a BS in economics/accounting from the University of Illinois.
Chief Operating Officer
Kevin Stineman is a leader, executive and general manager with 20+ years of experience building and leading commercial teams and operations. Kevin comes to Prescient from Morningstar, Inc, a global investment research company, where he spent 15 years and most recently led the Global Markets Group. In this role, he was responsible for operations in 26 countries with 400+ employees and annual revenue of $225 million. Over his career, Kevin has held leadership roles responsible in client service, software operations, product management, sales management and P&L management. Kevin has demonstrated his ability to enter and build businesses in new markets through developing and executing go-to-market strategies across a variety of business lines. He excels at building high-performing teams in marketing, sales, product development and service to drive revenue growth, scalability and profitability.
Kevin received his Bachelor of Arts from Dartmouth College in 1994 and an MBA in general management, marketing and technology from the Kellogg School of Management in 2002.
Chief Financial Officer
Mark Ibison joined Prescient Medicine as Chief Financial Officer in July 2019 with almost 20 years of finance and accounting leadership experience. Prior to joining Prescient Medicine, Mark was Divisional CFO at Thermo Fisher Scientific’s Biosciences Division, a global business with revenue in excess of $2.5B. Mark also served as Divisional CFO for Thermo Fisher Scientific’s Microbiology Division within the Specialty Diagnostics group. Earlier in his career, Mark held a number of finance leadership roles at Essentra, a UK-based FTSE 250 B2B manufacturer and distributor.
Over his career, Mark has held roles across the full spectrum of finance and accounting, supporting commercial teams to drive growth, manufacturing teams to improve profitability and as a strategic partner to general managers. He has also had operational responsibilities, managing procurement, distribution and continuous improvement functions.
Mark received his Bachelor of Laws (LLB) from Brunel University in London, UK. He is an Associate Member of both the Association of Corporate Treasurers (ACT) and the Chartered Institute of Management Accountants (CIMA).
Chief Commercial Officer
Tony Grover brings over 20 years of experience and expertise in business development, strategic partnerships, licensing, reimbursement and new technology platform development as an executive in the diagnostic and medical device industries. Tony has raised over $100M in cumulated capital, negotiated a variety of deals including licenses, strategic investment, joint ventures, and lab service agreements.
Most recently, Tony served as Vice President of Business Development for Banyan Biomarkers, where he was accountable for commercial activities in the US and global markets. Under his leadership, the company received the first FDA approval for a blood test to diagnose mild TBI, or concussion. Prior to Banyan Biomarkers, he was the Director of Marketing and Reimbursement at PhotoThera, a privately held medical device company developed a non-invasive laser for the treatment of ischemic stroke. Tony was also a management consultant for PRTM, now PwC, where he worked with a variety of Fortune 500 companies to increase operational efficiency.
Tony is the current Chairman of the BIOCOM Medical Device and Diagnostics Committee and on the Advisory Board of the Global Brain Health Coalition. He previously served as Chairman on the Board of Directors for the American Heart Association, San Diego. Tony is a Ronald E. McNair Scholar from Michigan State University with a B.S. in Biochemistry and has a M.B.A. from Carnegie Mellon University, Tepper School of Business.
Dr. Thomas W. Abendroth
Chief Medical Officer
Dr. Abendroth has worked at the intersection of medicine and IT for 35 years, focused on narrowing the gap between known best practice and its consistent use in everyday clinical care. He has a proven ability to lead and a combination of medical knowledge, clinical experience, healthcare IT practice, and business acumen that our rapidly growing business requires. Dr. Abendroth will guide our regulatory efforts for Predict and Prevent.
Dr. Abendroth served several leadership roles during his 29 years at Penn State’s academic health center, including Director of Programs in clinical laboratory, IT, and informatics; Assistant Dean in the College of Medicine; Chief Information Officer; and Chief of Medical Informatics. He co-founded Penn State’s Center for Quality Innovation and directed its data and analytics activities for the first 7 years.
Dr. Abendroth received his education and training at Amherst College (BA), the University of Maryland (MD), Penn State University (clinical pathology residency and informatics fellowship), and Harvard University (informatics fellowship).
Dr. Dave Cardamone
A frequent lecturer at prominent medical associations and educational institutions, Dave has more than 18 years of experience with the Hospital of the University of Pennsylvania. His roles have ranged from Lead Medical Technologist to Manager of Clinical Chemistry, and he was instrumental in bringing a range of new assays to the university laboratory—including STAT testing for adrenal vein sampling and improved testing for dialysis patients. Over the course of his professional career, Dave has been featured in over 20 industry publications. He is committed to meeting clients’ needs by providing customized toxicology panels, and holds a special passion for bringing rapid phenylketonuria testing to the market. He holds a BS in clinical laboratory science from Neumann University, an MS in clinical chemistry from West Chester University, and a PhD from the University of Medicine and Dentistry of New Jersey.
Chief Operating Officer - Louisville
Terry Minton is responsible for developing and executing operational priorities for the Prescient Medicine Louisville office. He has more than 30 years experience leading operations, business development and commercialization for multiple technologies. As the CEO of Aptamera, Inc. Mr. Minton led efforts resulting in the development of a cancer drug candidate from the bench to human clinical trials in a twenty-four month period. He has served as director of operations for a 700 employee division of a $500 million long-term care rehab company. Mr. Minton has also led initiatives including a multi-million dollar strategic partnership on behalf of Humana, Inc. leveraging personalized medicine technology. Mr. Minton’s depth and diversity of experience provide the Prescient Medicine Louisville office with strong and capable local leadership.
Dr. Mark W. Linder, PhD.,DABCC, FAACC
Laboratory Director – Louisville
Dr. Mark Linder has more than 15 years’ experience directing clinical pharmacogenetics laboratories and is the Medical Director of Prescient Medicine Louisville laboratory. Dr. Linder is a fellow of the National Academy of Clinical Biochemistry, a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC) and has served on a number of committees for the American Association for Clinical Chemistry, the International Association for Therapeutic Drug Monitoring and Clinical Toxicology and is a member of the International Federation for Clinical Chemistry Committee on Molecular Diagnostics. His scientific interests include development of circulating biomarkers for “liquid Biopsy” applications and expanding the science of pharmacogenetics into clinical laboratory practice. Dr. Linder has served as PI and MPI on numerous R01, K23, and SBIR grants and contracts.
Dr Linder is also Professor of the Department of Pathology and Laboratory Medicine at the University of Louisville. He serves as Associate Director the University of Louisville Hospital Laboratory and Assistant Director of the Clinical Chemistry Fellowship. Dr. Linder is a certified Clinical Laboratory Director in the areas of Clinical Chemistry, therapeutic drug monitoring, clinical toxicology and pharmacogenetics.
Dr. Beth A. McNally
Director of Laboratory Operations – Louisville
Dr. McNally has been immersed in the field of personalized medicine for nearly 20 years and is a passionate scientist and laboratory executive dedicated to advancing initiatives that foster precision medicine. She holds bachelor’s degree of science in Biology, two master’s degrees (Exercise Physiology and Teaching and Learning), and a Ph.D. in Pathology from The Ohio State University. She served as a NSRA training fellow and research fellow in the Departments of Surgery and Internal Medicine, Divisions of Immunotherapy, and Molecular Medicine and Genetics at The University of Michigan, as well as a postdoctoral fellow at The Research Institute at Nationwide Children’s Hospital. The depth and breadth of experience that she brings to Prescient Medicine is also enhanced by positions held at The Cleveland Clinic Lerner Research Institute. Dr. McNally has helped author over 20 peer reviewed journal articles and has presented at prominent local, national and international conferences. At Prescient Medicine, Dr. McNally directs a high complexity molecular laboratory and has been instrumental in ensuring accreditation, licensing and regulatory compliance with CAP and CLIA.
Vice President-Sales Operations
With over 15 years of direct sales experience in the healthcare industry, Jason has a proven track record as a dynamic sales professional. His impact at startups such as Vision BioSystems (later bought by Leica BioSystems) and GenMark Diagnostics included dramatically increased market share and surpassed sales goals—and he successfully built each of his regions from the ground up, creating multimillion-dollar revenue generators. Jason’s expertise in Six Sigma and Miller Heiman methodologies allowed him to move into management and training positions within larger organizations, from Dako North American to Leica BioSystems. His commitment to providing the absolute best customer service experience to his clients has helped Prescient rapidly expand its customer base and become a national leader in customer service support. Jason earned his bachelors of science from Penn State University.
Business Operations Manager
Outside of the laboratory, Caitlin works to maintain and improve operating efficiencies within Prescient Medicine’s ever-growing business verticals. She supervises all aspects of accounting, marketing, project management and insurance contracting, ensuring smooth workflow between the laboratory and corporate administration. Prior to joining Prescient Medicine, Caitlin worked for over 5 years in the real estate investment industry as a Project Coordinator, overseeing leasing, operations, construction, and development of 80,000+ square footage of laboratory space in the Central PA area. Caitlin graduated from Elizabethtown College with a Bachelors of Science in Business Administration with a concentration in Accounting.
Director of Application Development
With more than 25 years of experience in application development, Steve Wang is a proven project manager, team leader and full-stack developer. He serves as Director of Application Developement driving system architecture decisions, leading projects and developing multi-platform software solutions. He is an Innovator of next-generation solutions, systems and applications giving companies a competitive edge and producing outstanding results for customers.
Information Technology Manager
As an IT generalist in a world of increasing specialization, and with over 10 years’ experience in healthcare IT, Matt’s blend of experience and talents bring a mixture of tried-and-tested methodology and fresh perspective to the unique challenges of Prescient Medicine. Matt is responsible for all operational day-to-day technology needs, including laboratory information systems administration, infrastructure planning and deployment, internal & external user support, project management, change management, security, system integration, and process development. Before joining Prescient Medicine, Matt was with QS/1 Data Systems for 9 years and has extensive experience with legacy integration, troubleshooting, and project implementation with a specialization in streamlining existing processes. He holds multiple certifications from both Microsoft and CompTIA, actively serves on several technology and standards review boards, and has also worked as a small-business IT consultant with a focus on cost-effective solutions to problems. Matt has a degree in computer systems from YTI Career Institute.
Quality Assurance and Regulatory Affairs Manager
With more than 20 years of experience working in regulatory, quality, and techncial roles, Heather serves as Prescient Medicine’s Privacy Officer, Safety Officer, Document Control Manager, Quality Assurance Manager, and Regulatory Affairs Manager. She established the Quality Management System, implemented policies and procedures to meet all regulatory, accreditation, and standards of practice and is responsible for all regulatory affairs, quality assurance, and compliance activities. Heather held a variety of technical positions in start-ups, universities, and pharmaceutical companies prior to joining Prescient, most recently as the Clinical Laboratory Supervisor for Pacific Edge Diagnostics USA Ltd. where she established and managed the day-to-day operations of the laboratory and quality departments, instituted the Quality Management System, obtained laboratory licensing and accreditation, and validated their proprietary LDT. Heather holds a BS in Animal BioScience from the Pennsylvania State University.
Dr. Laurence M. Demers
Senior Scientific Advisor
A clinical biochemist at Prescient Medicine, Dr. Laurence M. Demers (DABCC, FACB) is an accomplished researcher, author of medical texts, and clinical trial investigator—within both the pharmaceutical and in vitro diagnostic industries. His research is concentrated in molecular diagnostics, laboratory automation, thyroid disease, metabolic bone disease and breast cancer, leading to authorship on over 720 publications. Dr. Demers’s past and present board memberships include standouts such as President of the American Association for Clinical Chemistry, President of the National Academy of Clinical Biochemistry, the founding Director of Clinical Chemistry at the M.S. Hershey Medical Center, founding Director of the Core Endocrine Laboratory in the Pennsylvania State University Hospital, Chairman of the Board of Trustees of Merrimack College, and Director of the Pennsylvania State Clinical Research Center Core Laboratory. A diplomate of the American Board of Clinical Chemistry and a fellow of the National Academy of Clinical Biochemistry, Dr. Demers holds a PhD in biochemistry from the State University of New York and an AB in biology from Merrimack College—where in 2011 he was awarded an honorary doctor of science. Dr. Demers is a distinguished professor emeritus of medicine and pathology at the Pennsylvania State University College of Medicine.